The global Alirocumab market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
Alirocumab is a human monoclonal antibody. It works by helping the liver reduce levels of "bad" cholesterol (low-density lipoprotein, or LDL) circulating in your blood.Alirocumab is used in adults with heart disease to lower the risk of heart attack, stroke, and certain types of chest pain conditions (unstable angina) requiring hospitalization.
The U.S. market size is estimated at $ million in 2024, while China is to reach $ million.
Patent segment will reach $ million by 2032, with a % CAGR in next six years.
The global key manufacturers of Alirocumab include AK Scientific, Carbosynth, TargetMol Chemicals, Beijing Aomi Jiade Pharmaceutical Technology, Hefei Hirisun Pharmatech, Hubei Widely Chemical Technology, Hubei Xingcheng Biotechnology, Hubei Zhongshan Medical Technology, Jiangxi Ruiweier Biotechnology, Kailide Biomedical Technology, etc. In 2024, the global top five players had a share approximately % in terms of revenue.
We have surveyed the Alirocumab manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Alirocumab, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alirocumab. This report contains market size and forecasts of Alirocumab in global, including the following market information:
Global Alirocumab market revenue, 2020-2025, 2026-2032, ($ millions)
Global Alirocumab market sales, 2020-2025, 2026-2032, (Kg)
Global top five Alirocumab companies in 2024 (%)
Total Market by Segment:
Global Alirocumab market, by Type, 2020-2025, 2026-2032 ($ millions) & (Kg)
Global Alirocumab market segment percentages, by Type, 2024 (%)
Patent
Generic
Global Alirocumab market, by Application, 2020-2025, 2026-2032 ($ Millions) & (Kg)
Global Alirocumab market segment percentages, by Application, 2024 (%)
Biochemical Reagents
Pharmaceutical Intermediates
Global Alirocumab market, by region and country, 2020-2025, 2026-2032 ($ millions) & (Kg)
Global Alirocumab market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Alirocumab revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Alirocumab revenues share in global market, 2024 (%)
Key companies Alirocumab sales in global market, 2020-2025 (estimated), (Kg)
Key companies Alirocumab sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
AK Scientific
Carbosynth
TargetMol Chemicals
Beijing Aomi Jiade Pharmaceutical Technology
Hefei Hirisun Pharmatech
Hubei Widely Chemical Technology
Hubei Xingcheng Biotechnology
Hubei Zhongshan Medical Technology
Jiangxi Ruiweier Biotechnology
Kailide Biomedical Technology
Nantong Feiyu Biological Technology
Nantong Hi-Future Biotechnology
Shanghai Baishikai Chemical Technology
Shanghai Biochempartner
Shanghai Loulan Biotechnology
Shanghai Macklin Biochemical
Shanghai Minkai Biotechnology
Shanghai Ruihui Chemical Technology
Shanghai Saimai Biotechnology
Shanghai Yifei Biotechnology
Sichuan Weiqi Biotechnology
Taizhou KEDE Chemical
Taizhou Kerui Bio-Technology
Tianmen Hengchang Chemical
WeiShi Reagent
Wuhan Dingxintong Pharmaceutical
Wuhan Fortuna Chemical
Wuhan Sunrise Technology Development
Wuhan Weisman Bioengineering
Outline of Major Chapters:
Chapter 1: Introduces the definition of Alirocumab, market overview.
Chapter 2: Global Alirocumab market size in revenue and volume.
Chapter 3: Detailed analysis of Alirocumab manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Alirocumab in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Alirocumab capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Alirocumab Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Alirocumab Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Alirocumab Overall Market Size
2.1 Global Alirocumab Market Size: 2024 VS 2032
2.2 Global Alirocumab Market Size, Prospects & Forecasts: 2020-2032
2.3 Global Alirocumab Sales: 2020-2032
3 Company Landscape
3.1 Top Alirocumab Players in Global Market
3.2 Top Global Alirocumab Companies Ranked by Revenue
3.3 Global Alirocumab Revenue by Companies
3.4 Global Alirocumab Sales by Companies
3.5 Global Alirocumab Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 Alirocumab Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers Alirocumab Product Type
3.8 Tier 1, Tier 2, and Tier 3 Alirocumab Players in Global Market
3.8.1 List of Global Tier 1 Alirocumab Companies
3.8.2 List of Global Tier 2 and Tier 3 Alirocumab Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type - Global Alirocumab Market Size Markets, 2024 & 2032
4.1.2 Patent
4.1.3 Generic
4.2 Segment by Type - Global Alirocumab Revenue & Forecasts
4.2.1 Segment by Type - Global Alirocumab Revenue, 2020-2025
4.2.2 Segment by Type - Global Alirocumab Revenue, 2026-2032
4.2.3 Segment by Type - Global Alirocumab Revenue Market Share, 2020-2032
4.3 Segment by Type - Global Alirocumab Sales & Forecasts
4.3.1 Segment by Type - Global Alirocumab Sales, 2020-2025
4.3.2 Segment by Type - Global Alirocumab Sales, 2026-2032
4.3.3 Segment by Type - Global Alirocumab Sales Market Share, 2020-2032
4.4 Segment by Type - Global Alirocumab Price (Manufacturers Selling Prices), 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application - Global Alirocumab Market Size, 2024 & 2032
5.1.2 Biochemical Reagents
5.1.3 Pharmaceutical Intermediates
5.2 Segment by Application - Global Alirocumab Revenue & Forecasts
5.2.1 Segment by Application - Global Alirocumab Revenue, 2020-2025
5.2.2 Segment by Application - Global Alirocumab Revenue, 2026-2032
5.2.3 Segment by Application - Global Alirocumab Revenue Market Share, 2020-2032
5.3 Segment by Application - Global Alirocumab Sales & Forecasts
5.3.1 Segment by Application - Global Alirocumab Sales, 2020-2025
5.3.2 Segment by Application - Global Alirocumab Sales, 2026-2032
5.3.3 Segment by Application - Global Alirocumab Sales Market Share, 2020-2032
5.4 Segment by Application - Global Alirocumab Price (Manufacturers Selling Prices), 2020-2032
6 Sights by Region
6.1 By Region - Global Alirocumab Market Size, 2024 & 2032
6.2 By Region - Global Alirocumab Revenue & Forecasts
6.2.1 By Region - Global Alirocumab Revenue, 2020-2025
6.2.2 By Region - Global Alirocumab Revenue, 2026-2032
6.2.3 By Region - Global Alirocumab Revenue Market Share, 2020-2032
6.3 By Region - Global Alirocumab Sales & Forecasts
6.3.1 By Region - Global Alirocumab Sales, 2020-2025
6.3.2 By Region - Global Alirocumab Sales, 2026-2032
6.3.3 By Region - Global Alirocumab Sales Market Share, 2020-2032
6.4 North America
6.4.1 By Country - North America Alirocumab Revenue, 2020-2032
6.4.2 By Country - North America Alirocumab Sales, 2020-2032
6.4.3 United States Alirocumab Market Size, 2020-2032
6.4.4 Canada Alirocumab Market Size, 2020-2032
6.4.5 Mexico Alirocumab Market Size, 2020-2032
6.5 Europe
6.5.1 By Country - Europe Alirocumab Revenue, 2020-2032
6.5.2 By Country - Europe Alirocumab Sales, 2020-2032
6.5.3 Germany Alirocumab Market Size, 2020-2032
6.5.4 France Alirocumab Market Size, 2020-2032
6.5.5 U.K. Alirocumab Market Size, 2020-2032
6.5.6 Italy Alirocumab Market Size, 2020-2032
6.5.7 Russia Alirocumab Market Size, 2020-2032
6.5.8 Nordic Countries Alirocumab Market Size, 2020-2032
6.5.9 Benelux Alirocumab Market Size, 2020-2032
6.6 Asia
6.6.1 By Region - Asia Alirocumab Revenue, 2020-2032
6.6.2 By Region - Asia Alirocumab Sales, 2020-2032
6.6.3 China Alirocumab Market Size, 2020-2032
6.6.4 Japan Alirocumab Market Size, 2020-2032
6.6.5 South Korea Alirocumab Market Size, 2020-2032
6.6.6 Southeast Asia Alirocumab Market Size, 2020-2032
6.6.7 India Alirocumab Market Size, 2020-2032
6.7 South America
6.7.1 By Country - South America Alirocumab Revenue, 2020-2032
6.7.2 By Country - South America Alirocumab Sales, 2020-2032
6.7.3 Brazil Alirocumab Market Size, 2020-2032
6.7.4 Argentina Alirocumab Market Size, 2020-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Alirocumab Revenue, 2020-2032
6.8.2 By Country - Middle East & Africa Alirocumab Sales, 2020-2032
6.8.3 Turkey Alirocumab Market Size, 2020-2032
6.8.4 Israel Alirocumab Market Size, 2020-2032
6.8.5 Saudi Arabia Alirocumab Market Size, 2020-2032
6.8.6 UAE Alirocumab Market Size, 2020-2032
7 Manufacturers & Brands Profiles
7.1 AK Scientific
7.1.1 AK Scientific Company Summary
7.1.2 AK Scientific Business Overview
7.1.3 AK Scientific Alirocumab Major Product Offerings
7.1.4 AK Scientific Alirocumab Sales and Revenue in Global (2020-2025)
7.1.5 AK Scientific Key News & Latest Developments
7.2 Carbosynth
7.2.1 Carbosynth Company Summary
7.2.2 Carbosynth Business Overview
7.2.3 Carbosynth Alirocumab Major Product Offerings
7.2.4 Carbosynth Alirocumab Sales and Revenue in Global (2020-2025)
7.2.5 Carbosynth Key News & Latest Developments
7.3 TargetMol Chemicals
7.3.1 TargetMol Chemicals Company Summary
7.3.2 TargetMol Chemicals Business Overview
7.3.3 TargetMol Chemicals Alirocumab Major Product Offerings
7.3.4 TargetMol Chemicals Alirocumab Sales and Revenue in Global (2020-2025)
7.3.5 TargetMol Chemicals Key News & Latest Developments
7.4 Beijing Aomi Jiade Pharmaceutical Technology
7.4.1 Beijing Aomi Jiade Pharmaceutical Technology Company Summary
7.4.2 Beijing Aomi Jiade Pharmaceutical Technology Business Overview
7.4.3 Beijing Aomi Jiade Pharmaceutical Technology Alirocumab Major Product Offerings
7.4.4 Beijing Aomi Jiade Pharmaceutical Technology Alirocumab Sales and Revenue in Global (2020-2025)
7.4.5 Beijing Aomi Jiade Pharmaceutical Technology Key News & Latest Developments
7.5 Hefei Hirisun Pharmatech
7.5.1 Hefei Hirisun Pharmatech Company Summary
7.5.2 Hefei Hirisun Pharmatech Business Overview
7.5.3 Hefei Hirisun Pharmatech Alirocumab Major Product Offerings
7.5.4 Hefei Hirisun Pharmatech Alirocumab Sales and Revenue in Global (2020-2025)
7.5.5 Hefei Hirisun Pharmatech Key News & Latest Developments
7.6 Hubei Widely Chemical Technology
7.6.1 Hubei Widely Chemical Technology Company Summary
7.6.2 Hubei Widely Chemical Technology Business Overview
7.6.3 Hubei Widely Chemical Technology Alirocumab Major Product Offerings
7.6.4 Hubei Widely Chemical Technology Alirocumab Sales and Revenue in Global (2020-2025)
7.6.5 Hubei Widely Chemical Technology Key News & Latest Developments
7.7 Hubei Xingcheng Biotechnology
7.7.1 Hubei Xingcheng Biotechnology Company Summary
7.7.2 Hubei Xingcheng Biotechnology Business Overview
7.7.3 Hubei Xingcheng Biotechnology Alirocumab Major Product Offerings
7.7.4 Hubei Xingcheng Biotechnology Alirocumab Sales and Revenue in Global (2020-2025)
7.7.5 Hubei Xingcheng Biotechnology Key News & Latest Developments
7.8 Hubei Zhongshan Medical Technology
7.8.1 Hubei Zhongshan Medical Technology Company Summary
7.8.2 Hubei Zhongshan Medical Technology Business Overview
7.8.3 Hubei Zhongshan Medical Technology Alirocumab Major Product Offerings
7.8.4 Hubei Zhongshan Medical Technology Alirocumab Sales and Revenue in Global (2020-2025)
7.8.5 Hubei Zhongshan Medical Technology Key News & Latest Developments
7.9 Jiangxi Ruiweier Biotechnology
7.9.1 Jiangxi Ruiweier Biotechnology Company Summary
7.9.2 Jiangxi Ruiweier Biotechnology Business Overview
7.9.3 Jiangxi Ruiweier Biotechnology Alirocumab Major Product Offerings
7.9.4 Jiangxi Ruiweier Biotechnology Alirocumab Sales and Revenue in Global (2020-2025)
7.9.5 Jiangxi Ruiweier Biotechnology Key News & Latest Developments
7.10 Kailide Biomedical Technology
7.10.1 Kailide Biomedical Technology Company Summary
7.10.2 Kailide Biomedical Technology Business Overview
7.10.3 Kailide Biomedical Technology Alirocumab Major Product Offerings
7.10.4 Kailide Biomedical Technology Alirocumab Sales and Revenue in Global (2020-2025)
7.10.5 Kailide Biomedical Technology Key News & Latest Developments
7.11 Nantong Feiyu Biological Technology
7.11.1 Nantong Feiyu Biological Technology Company Summary
7.11.2 Nantong Feiyu Biological Technology Business Overview
7.11.3 Nantong Feiyu Biological Technology Alirocumab Major Product Offerings
7.11.4 Nantong Feiyu Biological Technology Alirocumab Sales and Revenue in Global (2020-2025)
7.11.5 Nantong Feiyu Biological Technology Key News & Latest Developments
7.12 Nantong Hi-Future Biotechnology
7.12.1 Nantong Hi-Future Biotechnology Company Summary
7.12.2 Nantong Hi-Future Biotechnology Business Overview
7.12.3 Nantong Hi-Future Biotechnology Alirocumab Major Product Offerings
7.12.4 Nantong Hi-Future Biotechnology Alirocumab Sales and Revenue in Global (2020-2025)
7.12.5 Nantong Hi-Future Biotechnology Key News & Latest Developments
7.13 Shanghai Baishikai Chemical Technology
7.13.1 Shanghai Baishikai Chemical Technology Company Summary
7.13.2 Shanghai Baishikai Chemical Technology Business Overview
7.13.3 Shanghai Baishikai Chemical Technology Alirocumab Major Product Offerings
7.13.4 Shanghai Baishikai Chemical Technology Alirocumab Sales and Revenue in Global (2020-2025)
7.13.5 Shanghai Baishikai Chemical Technology Key News & Latest Developments
7.14 Shanghai Biochempartner
7.14.1 Shanghai Biochempartner Company Summary
7.14.2 Shanghai Biochempartner Business Overview
7.14.3 Shanghai Biochempartner Alirocumab Major Product Offerings
7.14.4 Shanghai Biochempartner Alirocumab Sales and Revenue in Global (2020-2025)
7.14.5 Shanghai Biochempartner Key News & Latest Developments
7.15 Shanghai Loulan Biotechnology
7.15.1 Shanghai Loulan Biotechnology Company Summary
7.15.2 Shanghai Loulan Biotechnology Business Overview
7.15.3 Shanghai Loulan Biotechnology Alirocumab Major Product Offerings
7.15.4 Shanghai Loulan Biotechnology Alirocumab Sales and Revenue in Global (2020-2025)
7.15.5 Shanghai Loulan Biotechnology Key News & Latest Developments
7.16 Shanghai Macklin Biochemical
7.16.1 Shanghai Macklin Biochemical Company Summary
7.16.2 Shanghai Macklin Biochemical Business Overview
7.16.3 Shanghai Macklin Biochemical Alirocumab Major Product Offerings
7.16.4 Shanghai Macklin Biochemical Alirocumab Sales and Revenue in Global (2020-2025)
7.16.5 Shanghai Macklin Biochemical Key News & Latest Developments
7.17 Shanghai Minkai Biotechnology
7.17.1 Shanghai Minkai Biotechnology Company Summary
7.17.2 Shanghai Minkai Biotechnology Business Overview
7.17.3 Shanghai Minkai Biotechnology Alirocumab Major Product Offerings
7.17.4 Shanghai Minkai Biotechnology Alirocumab Sales and Revenue in Global (2020-2025)
7.17.5 Shanghai Minkai Biotechnology Key News & Latest Developments
7.18 Shanghai Ruihui Chemical Technology
7.18.1 Shanghai Ruihui Chemical Technology Company Summary
7.18.2 Shanghai Ruihui Chemical Technology Business Overview
7.18.3 Shanghai Ruihui Chemical Technology Alirocumab Major Product Offerings
7.18.4 Shanghai Ruihui Chemical Technology Alirocumab Sales and Revenue in Global (2020-2025)
7.18.5 Shanghai Ruihui Chemical Technology Key News & Latest Developments
7.19 Shanghai Saimai Biotechnology
7.19.1 Shanghai Saimai Biotechnology Company Summary
7.19.2 Shanghai Saimai Biotechnology Business Overview
7.19.3 Shanghai Saimai Biotechnology Alirocumab Major Product Offerings
7.19.4 Shanghai Saimai Biotechnology Alirocumab Sales and Revenue in Global (2020-2025)
7.19.5 Shanghai Saimai Biotechnology Key News & Latest Developments
7.20 Shanghai Yifei Biotechnology
7.20.1 Shanghai Yifei Biotechnology Company Summary
7.20.2 Shanghai Yifei Biotechnology Business Overview
7.20.3 Shanghai Yifei Biotechnology Alirocumab Major Product Offerings
7.20.4 Shanghai Yifei Biotechnology Alirocumab Sales and Revenue in Global (2020-2025)
7.20.5 Shanghai Yifei Biotechnology Key News & Latest Developments
7.21 Sichuan Weiqi Biotechnology
7.21.1 Sichuan Weiqi Biotechnology Company Summary
7.21.2 Sichuan Weiqi Biotechnology Business Overview
7.21.3 Sichuan Weiqi Biotechnology Alirocumab Major Product Offerings
7.21.4 Sichuan Weiqi Biotechnology Alirocumab Sales and Revenue in Global (2020-2025)
7.21.5 Sichuan Weiqi Biotechnology Key News & Latest Developments
7.22 Taizhou KEDE Chemical
7.22.1 Taizhou KEDE Chemical Company Summary
7.22.2 Taizhou KEDE Chemical Business Overview
7.22.3 Taizhou KEDE Chemical Alirocumab Major Product Offerings
7.22.4 Taizhou KEDE Chemical Alirocumab Sales and Revenue in Global (2020-2025)
7.22.5 Taizhou KEDE Chemical Key News & Latest Developments
7.23 Taizhou Kerui Bio-Technology
7.23.1 Taizhou Kerui Bio-Technology Company Summary
7.23.2 Taizhou Kerui Bio-Technology Business Overview
7.23.3 Taizhou Kerui Bio-Technology Alirocumab Major Product Offerings
7.23.4 Taizhou Kerui Bio-Technology Alirocumab Sales and Revenue in Global (2020-2025)
7.23.5 Taizhou Kerui Bio-Technology Key News & Latest Developments
7.24 Tianmen Hengchang Chemical
7.24.1 Tianmen Hengchang Chemical Company Summary
7.24.2 Tianmen Hengchang Chemical Business Overview
7.24.3 Tianmen Hengchang Chemical Alirocumab Major Product Offerings
7.24.4 Tianmen Hengchang Chemical Alirocumab Sales and Revenue in Global (2020-2025)
7.24.5 Tianmen Hengchang Chemical Key News & Latest Developments
7.25 WeiShi Reagent
7.25.1 WeiShi Reagent Company Summary
7.25.2 WeiShi Reagent Business Overview
7.25.3 WeiShi Reagent Alirocumab Major Product Offerings
7.25.4 WeiShi Reagent Alirocumab Sales and Revenue in Global (2020-2025)
7.25.5 WeiShi Reagent Key News & Latest Developments
7.26 Wuhan Dingxintong Pharmaceutical
7.26.1 Wuhan Dingxintong Pharmaceutical Company Summary
7.26.2 Wuhan Dingxintong Pharmaceutical Business Overview
7.26.3 Wuhan Dingxintong Pharmaceutical Alirocumab Major Product Offerings
7.26.4 Wuhan Dingxintong Pharmaceutical Alirocumab Sales and Revenue in Global (2020-2025)
7.26.5 Wuhan Dingxintong Pharmaceutical Key News & Latest Developments
7.27 Wuhan Fortuna Chemical
7.27.1 Wuhan Fortuna Chemical Company Summary
7.27.2 Wuhan Fortuna Chemical Business Overview
7.27.3 Wuhan Fortuna Chemical Alirocumab Major Product Offerings
7.27.4 Wuhan Fortuna Chemical Alirocumab Sales and Revenue in Global (2020-2025)
7.27.5 Wuhan Fortuna Chemical Key News & Latest Developments
7.28 Wuhan Sunrise Technology Development
7.28.1 Wuhan Sunrise Technology Development Company Summary
7.28.2 Wuhan Sunrise Technology Development Business Overview
7.28.3 Wuhan Sunrise Technology Development Alirocumab Major Product Offerings
7.28.4 Wuhan Sunrise Technology Development Alirocumab Sales and Revenue in Global (2020-2025)
7.28.5 Wuhan Sunrise Technology Development Key News & Latest Developments
7.29 Wuhan Weisman Bioengineering
7.29.1 Wuhan Weisman Bioengineering Company Summary
7.29.2 Wuhan Weisman Bioengineering Business Overview
7.29.3 Wuhan Weisman Bioengineering Alirocumab Major Product Offerings
7.29.4 Wuhan Weisman Bioengineering Alirocumab Sales and Revenue in Global (2020-2025)
7.29.5 Wuhan Weisman Bioengineering Key News & Latest Developments
8 Global Alirocumab Production Capacity, Analysis
8.1 Global Alirocumab Production Capacity, 2020-2032
8.2 Alirocumab Production Capacity of Key Manufacturers in Global Market
8.3 Global Alirocumab Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Alirocumab Supply Chain Analysis
10.1 Alirocumab Industry Value Chain
10.2 Alirocumab Upstream Market
10.3 Alirocumab Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Alirocumab Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Alirocumab in Global Market
Table 2. Top Alirocumab Players in Global Market, Ranking by Revenue (2024)
Table 3. Global Alirocumab Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global Alirocumab Revenue Share by Companies, 2020-2025
Table 5. Global Alirocumab Sales by Companies, (Kg), 2020-2025
Table 6. Global Alirocumab Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers Alirocumab Price (2020-2025) & (US$/Kg)
Table 8. Global Manufacturers Alirocumab Product Type
Table 9. List of Global Tier 1 Alirocumab Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Alirocumab Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type � Global Alirocumab Revenue, (US$, Mn), 2024 & 2032
Table 12. Segment by Type - Global Alirocumab Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global Alirocumab Revenue (US$, Mn), 2026-2032
Table 14. Segment by Type - Global Alirocumab Sales (Kg), 2020-2025
Table 15. Segment by Type - Global Alirocumab Sales (Kg), 2026-2032
Table 16. Segment by Application � Global Alirocumab Revenue, (US$, Mn), 2024 & 2032
Table 17. Segment by Application - Global Alirocumab Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global Alirocumab Revenue, (US$, Mn), 2026-2032
Table 19. Segment by Application - Global Alirocumab Sales, (Kg), 2020-2025
Table 20. Segment by Application - Global Alirocumab Sales, (Kg), 2026-2032
Table 21. By Region � Global Alirocumab Revenue, (US$, Mn), 2025-2032
Table 22. By Region - Global Alirocumab Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global Alirocumab Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Global Alirocumab Sales, (Kg), 2020-2025
Table 25. By Region - Global Alirocumab Sales, (Kg), 2026-2032
Table 26. By Country - North America Alirocumab Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America Alirocumab Revenue, (US$, Mn), 2026-2032
Table 28. By Country - North America Alirocumab Sales, (Kg), 2020-2025
Table 29. By Country - North America Alirocumab Sales, (Kg), 2026-2032
Table 30. By Country - Europe Alirocumab Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe Alirocumab Revenue, (US$, Mn), 2026-2032
Table 32. By Country - Europe Alirocumab Sales, (Kg), 2020-2025
Table 33. By Country - Europe Alirocumab Sales, (Kg), 2026-2032
Table 34. By Region - Asia Alirocumab Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia Alirocumab Revenue, (US$, Mn), 2026-2032
Table 36. By Region - Asia Alirocumab Sales, (Kg), 2020-2025
Table 37. By Region - Asia Alirocumab Sales, (Kg), 2026-2032
Table 38. By Country - South America Alirocumab Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America Alirocumab Revenue, (US$, Mn), 2026-2032
Table 40. By Country - South America Alirocumab Sales, (Kg), 2020-2025
Table 41. By Country - South America Alirocumab Sales, (Kg), 2026-2032
Table 42. By Country - Middle East & Africa Alirocumab Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa Alirocumab Revenue, (US$, Mn), 2026-2032
Table 44. By Country - Middle East & Africa Alirocumab Sales, (Kg), 2020-2025
Table 45. By Country - Middle East & Africa Alirocumab Sales, (Kg), 2026-2032
Table 46. AK Scientific Company Summary
Table 47. AK Scientific Alirocumab Product Offerings
Table 48. AK Scientific Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 49. AK Scientific Key News & Latest Developments
Table 50. Carbosynth Company Summary
Table 51. Carbosynth Alirocumab Product Offerings
Table 52. Carbosynth Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 53. Carbosynth Key News & Latest Developments
Table 54. TargetMol Chemicals Company Summary
Table 55. TargetMol Chemicals Alirocumab Product Offerings
Table 56. TargetMol Chemicals Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 57. TargetMol Chemicals Key News & Latest Developments
Table 58. Beijing Aomi Jiade Pharmaceutical Technology Company Summary
Table 59. Beijing Aomi Jiade Pharmaceutical Technology Alirocumab Product Offerings
Table 60. Beijing Aomi Jiade Pharmaceutical Technology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 61. Beijing Aomi Jiade Pharmaceutical Technology Key News & Latest Developments
Table 62. Hefei Hirisun Pharmatech Company Summary
Table 63. Hefei Hirisun Pharmatech Alirocumab Product Offerings
Table 64. Hefei Hirisun Pharmatech Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 65. Hefei Hirisun Pharmatech Key News & Latest Developments
Table 66. Hubei Widely Chemical Technology Company Summary
Table 67. Hubei Widely Chemical Technology Alirocumab Product Offerings
Table 68. Hubei Widely Chemical Technology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 69. Hubei Widely Chemical Technology Key News & Latest Developments
Table 70. Hubei Xingcheng Biotechnology Company Summary
Table 71. Hubei Xingcheng Biotechnology Alirocumab Product Offerings
Table 72. Hubei Xingcheng Biotechnology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 73. Hubei Xingcheng Biotechnology Key News & Latest Developments
Table 74. Hubei Zhongshan Medical Technology Company Summary
Table 75. Hubei Zhongshan Medical Technology Alirocumab Product Offerings
Table 76. Hubei Zhongshan Medical Technology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 77. Hubei Zhongshan Medical Technology Key News & Latest Developments
Table 78. Jiangxi Ruiweier Biotechnology Company Summary
Table 79. Jiangxi Ruiweier Biotechnology Alirocumab Product Offerings
Table 80. Jiangxi Ruiweier Biotechnology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 81. Jiangxi Ruiweier Biotechnology Key News & Latest Developments
Table 82. Kailide Biomedical Technology Company Summary
Table 83. Kailide Biomedical Technology Alirocumab Product Offerings
Table 84. Kailide Biomedical Technology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 85. Kailide Biomedical Technology Key News & Latest Developments
Table 86. Nantong Feiyu Biological Technology Company Summary
Table 87. Nantong Feiyu Biological Technology Alirocumab Product Offerings
Table 88. Nantong Feiyu Biological Technology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 89. Nantong Feiyu Biological Technology Key News & Latest Developments
Table 90. Nantong Hi-Future Biotechnology Company Summary
Table 91. Nantong Hi-Future Biotechnology Alirocumab Product Offerings
Table 92. Nantong Hi-Future Biotechnology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 93. Nantong Hi-Future Biotechnology Key News & Latest Developments
Table 94. Shanghai Baishikai Chemical Technology Company Summary
Table 95. Shanghai Baishikai Chemical Technology Alirocumab Product Offerings
Table 96. Shanghai Baishikai Chemical Technology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 97. Shanghai Baishikai Chemical Technology Key News & Latest Developments
Table 98. Shanghai Biochempartner Company Summary
Table 99. Shanghai Biochempartner Alirocumab Product Offerings
Table 100. Shanghai Biochempartner Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 101. Shanghai Biochempartner Key News & Latest Developments
Table 102. Shanghai Loulan Biotechnology Company Summary
Table 103. Shanghai Loulan Biotechnology Alirocumab Product Offerings
Table 104. Shanghai Loulan Biotechnology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 105. Shanghai Loulan Biotechnology Key News & Latest Developments
Table 106. Shanghai Macklin Biochemical Company Summary
Table 107. Shanghai Macklin Biochemical Alirocumab Product Offerings
Table 108. Shanghai Macklin Biochemical Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 109. Shanghai Macklin Biochemical Key News & Latest Developments
Table 110. Shanghai Minkai Biotechnology Company Summary
Table 111. Shanghai Minkai Biotechnology Alirocumab Product Offerings
Table 112. Shanghai Minkai Biotechnology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 113. Shanghai Minkai Biotechnology Key News & Latest Developments
Table 114. Shanghai Ruihui Chemical Technology Company Summary
Table 115. Shanghai Ruihui Chemical Technology Alirocumab Product Offerings
Table 116. Shanghai Ruihui Chemical Technology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 117. Shanghai Ruihui Chemical Technology Key News & Latest Developments
Table 118. Shanghai Saimai Biotechnology Company Summary
Table 119. Shanghai Saimai Biotechnology Alirocumab Product Offerings
Table 120. Shanghai Saimai Biotechnology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 121. Shanghai Saimai Biotechnology Key News & Latest Developments
Table 122. Shanghai Yifei Biotechnology Company Summary
Table 123. Shanghai Yifei Biotechnology Alirocumab Product Offerings
Table 124. Shanghai Yifei Biotechnology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 125. Shanghai Yifei Biotechnology Key News & Latest Developments
Table 126. Sichuan Weiqi Biotechnology Company Summary
Table 127. Sichuan Weiqi Biotechnology Alirocumab Product Offerings
Table 128. Sichuan Weiqi Biotechnology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 129. Sichuan Weiqi Biotechnology Key News & Latest Developments
Table 130. Taizhou KEDE Chemical Company Summary
Table 131. Taizhou KEDE Chemical Alirocumab Product Offerings
Table 132. Taizhou KEDE Chemical Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 133. Taizhou KEDE Chemical Key News & Latest Developments
Table 134. Taizhou Kerui Bio-Technology Company Summary
Table 135. Taizhou Kerui Bio-Technology Alirocumab Product Offerings
Table 136. Taizhou Kerui Bio-Technology Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 137. Taizhou Kerui Bio-Technology Key News & Latest Developments
Table 138. Tianmen Hengchang Chemical Company Summary
Table 139. Tianmen Hengchang Chemical Alirocumab Product Offerings
Table 140. Tianmen Hengchang Chemical Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 141. Tianmen Hengchang Chemical Key News & Latest Developments
Table 142. WeiShi Reagent Company Summary
Table 143. WeiShi Reagent Alirocumab Product Offerings
Table 144. WeiShi Reagent Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 145. WeiShi Reagent Key News & Latest Developments
Table 146. Wuhan Dingxintong Pharmaceutical Company Summary
Table 147. Wuhan Dingxintong Pharmaceutical Alirocumab Product Offerings
Table 148. Wuhan Dingxintong Pharmaceutical Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 149. Wuhan Dingxintong Pharmaceutical Key News & Latest Developments
Table 150. Wuhan Fortuna Chemical Company Summary
Table 151. Wuhan Fortuna Chemical Alirocumab Product Offerings
Table 152. Wuhan Fortuna Chemical Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 153. Wuhan Fortuna Chemical Key News & Latest Developments
Table 154. Wuhan Sunrise Technology Development Company Summary
Table 155. Wuhan Sunrise Technology Development Alirocumab Product Offerings
Table 156. Wuhan Sunrise Technology Development Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 157. Wuhan Sunrise Technology Development Key News & Latest Developments
Table 158. Wuhan Weisman Bioengineering Company Summary
Table 159. Wuhan Weisman Bioengineering Alirocumab Product Offerings
Table 160. Wuhan Weisman Bioengineering Alirocumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) & (2020-2025)
Table 161. Wuhan Weisman Bioengineering Key News & Latest Developments
Table 162. Alirocumab Capacity of Key Manufacturers in Global Market, 2023-2025 (Kg)
Table 163. Global Alirocumab Capacity Market Share of Key Manufacturers, 2023-2025
Table 164. Global Alirocumab Production by Region, 2020-2025 (Kg)
Table 165. Global Alirocumab Production by Region, 2026-2032 (Kg)
Table 166. Alirocumab Market Opportunities & Trends in Global Market
Table 167. Alirocumab Market Drivers in Global Market
Table 168. Alirocumab Market Restraints in Global Market
Table 169. Alirocumab Raw Materials
Table 170. Alirocumab Raw Materials Suppliers in Global Market
Table 171. Typical Alirocumab Downstream
Table 172. Alirocumab Downstream Clients in Global Market
Table 173. Alirocumab Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Alirocumab Product Picture
Figure 2. Alirocumab Segment by Type in 2024
Figure 3. Alirocumab Segment by Application in 2024
Figure 4. Global Alirocumab Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Alirocumab Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Alirocumab Revenue: 2020-2032 (US$, Mn)
Figure 8. Alirocumab Sales in Global Market: 2020-2032 (Kg)
Figure 9. The Top 3 and 5 Players Market Share by Alirocumab Revenue in 2024
Figure 10. Segment by Type � Global Alirocumab Revenue, (US$, Mn), 2024 & 2032
Figure 11. Segment by Type - Global Alirocumab Revenue Market Share, 2020-2032
Figure 12. Segment by Type - Global Alirocumab Sales Market Share, 2020-2032
Figure 13. Segment by Type - Global Alirocumab Price (US$/Kg), 2020-2032
Figure 14. Segment by Application � Global Alirocumab Revenue, (US$, Mn), 2024 & 2032
Figure 15. Segment by Application - Global Alirocumab Revenue Market Share, 2020-2032
Figure 16. Segment by Application - Global Alirocumab Sales Market Share, 2020-2032
Figure 17. Segment by Application -Global Alirocumab Price (US$/Kg), 2020-2032
Figure 18. By Region � Global Alirocumab Revenue, (US$, Mn), 2025 & 2032
Figure 19. By Region - Global Alirocumab Revenue Market Share, 2020 VS 2024 VS 2032
Figure 20. By Region - Global Alirocumab Revenue Market Share, 2020-2032
Figure 21. By Region - Global Alirocumab Sales Market Share, 2020-2032
Figure 22. By Country - North America Alirocumab Revenue Market Share, 2020-2032
Figure 23. By Country - North America Alirocumab Sales Market Share, 2020-2032
Figure 24. United States Alirocumab Revenue, (US$, Mn), 2020-2032
Figure 25. Canada Alirocumab Revenue, (US$, Mn), 2020-2032
Figure 26. Mexico Alirocumab Revenue, (US$, Mn), 2020-2032
Figure 27. By Country - Europe Alirocumab Revenue Market Share, 2020-2032
Figure 28. By Country - Europe Alirocumab Sales Market Share, 2020-2032
Figure 29. Germany Alirocumab Revenue, (US$, Mn), 2020-2032
Figure 30. France Alirocumab Revenue, (US$, Mn), 2020-2032
Figure 31. U.K. Alirocumab Revenue, (US$, Mn), 2020-2032
Figure 32. Italy Alirocumab Revenue, (US$, Mn), 2020-2032
Figure 33. Russia Alirocumab Revenue, (US$, Mn), 2020-2032
Figure 34. Nordic Countries Alirocumab Revenue, (US$, Mn), 2020-2032
Figure 35. Benelux Alirocumab Revenue, (US$, Mn), 2020-2032
Figure 36. By Region - Asia Alirocumab Revenue Market Share, 2020-2032
Figure 37. By Region - Asia Alirocumab Sales Market Share, 2020-2032
Figure 38. China Alirocumab Revenue, (US$, Mn), 2020-2032
Figure 39. Japan Alirocumab Revenue, (US$, Mn), 2020-2032
Figure 40. South Korea Alirocumab Revenue, (US$, Mn), 2020-2032
Figure 41. Southeast Asia Alirocumab Revenue, (US$, Mn), 2020-2032
Figure 42. India Alirocumab Revenue, (US$, Mn), 2020-2032
Figure 43. By Country - South America Alirocumab Revenue Market Share, 2020-2032
Figure 44. By Country - South America Alirocumab Sales, Market Share, 2020-2032
Figure 45. Brazil Alirocumab Revenue, (US$, Mn), 2020-2032
Figure 46. Argentina Alirocumab Revenue, (US$, Mn), 2020-2032
Figure 47. By Country - Middle East & Africa Alirocumab Revenue, Market Share, 2020-2032
Figure 48. By Country - Middle East & Africa Alirocumab Sales, Market Share, 2020-2032
Figure 49. Turkey Alirocumab Revenue, (US$, Mn), 2020-2032
Figure 50. Israel Alirocumab Revenue, (US$, Mn), 2020-2032
Figure 51. Saudi Arabia Alirocumab Revenue, (US$, Mn), 2020-2032
Figure 52. UAE Alirocumab Revenue, (US$, Mn), 2020-2032
Figure 53. Global Alirocumab Production Capacity (Kg), 2020-2032
Figure 54. The Percentage of Production Alirocumab by Region, 2024 VS 2032
Figure 55. Alirocumab Industry Value Chain
Figure 56. Marketing Channels
